Cargando…
Direct oral anticoagulant use in left ventricular thrombus
Left ventricular thrombus (LVT) is associated with a significant risk of ischemic stroke (IS) and peripheral embolization. Societal guidelines recommend the use of warfarin, with direct oral anticoagulants (DOACs) only for patients unable to tolerate warfarin. We studied the natural history of LVT w...
Autores principales: | Ali, Zafar, Isom, Nicholas, Dalia, Tarun, Sami, Farhad, Mahmood, Uzair, Shah, Zubair, Gupta, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596944/ https://www.ncbi.nlm.nih.gov/pubmed/33132763 http://dx.doi.org/10.1186/s12959-020-00242-x |
Ejemplares similares
-
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
por: Dalia, Tarun, et al.
Publicado: (2021) -
Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
por: Iqbal, Hansa, et al.
Publicado: (2020) -
Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
por: Badescu, Minerva Codruta, et al.
Publicado: (2023) -
Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus
por: Huang, Lei, et al.
Publicado: (2022) -
Efficacy of direct oral anticoagulants on the resolution of left ventricular thrombus—A case series and literature review
por: Bahmaid, Reem A, et al.
Publicado: (2019)